Your browser doesn't support javascript.
loading
Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth.
Papadopoulou, Maria; Dimova, Tanya; Shey, Muki; Briel, Libby; Veldtsman, Helen; Khomba, Nondumiso; Africa, Hadn; Steyn, Marcia; Hanekom, Willem A; Scriba, Thomas J; Nemes, Elisa; Vermijlen, David.
Afiliação
  • Papadopoulou M; Department of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.
  • Dimova T; Institute for Medical Immunology, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.
  • Shey M; ULB Center for Research in Immunology (U-CRI), 1050 Brussels, Belgium.
  • Briel L; U-CRI, 6041 Gosselies, Belgium.
  • Veldtsman H; Institute for Medical Immunology, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium.
  • Khomba N; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Division of Immunology, University of Cape Town, 7925 Observatory, South Africa.
  • Africa H; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Division of Immunology, University of Cape Town, 7925 Observatory, South Africa.
  • Steyn M; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Division of Immunology, University of Cape Town, 7925 Observatory, South Africa.
  • Hanekom WA; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Division of Immunology, University of Cape Town, 7925 Observatory, South Africa.
  • Scriba TJ; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Division of Immunology, University of Cape Town, 7925 Observatory, South Africa.
  • Nemes E; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Division of Immunology, University of Cape Town, 7925 Observatory, South Africa.
  • Vermijlen D; South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, Department of Pathology, Division of Immunology, University of Cape Town, 7925 Observatory, South Africa.
Proc Natl Acad Sci U S A ; 117(31): 18638-18648, 2020 08 04.
Article em En | MEDLINE | ID: mdl-32665435
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Subpopulações de Linfócitos T / Receptores de Antígenos de Linfócitos T gama-delta Limite: Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Subpopulações de Linfócitos T / Receptores de Antígenos de Linfócitos T gama-delta Limite: Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2020 Tipo de documento: Article